Review of stent coating strategies: Clinical insights
Source abstract
Abstract
Despite advances in stent design, expansion techniques and anti-thrombotic agents to improve pharmacological control of subacute thrombosis (SAT) and to reduce to 2 the occlusive thrombosis rates, a significant risk of mortality associated with thrombotic vascular occlusion due to the adhesion of blood constituents remains a problem for patients with more complex lesions. The adhesion process is greatly governed by the surface characteristics, mainly the surface chemical composition, surface morphology, presence of charge, surface wettability and surface roughness. Surface chemical inertness (reduced interaction with chemicals and biological components) subsequently became the primary criteria which guided the development of non thrombotic stents as well as other blood-contacting materials. A number of strategies have been adopted in an effort to coat the stent with or without the use of a drug delivery system, to overcome the thrombus formation, to minimize the stent occlusion and to improve the overall hemocompatibility of the device. This paper aims at reviewing the clinical outcomes of main non-pharmaceutical stent coating procedures and their clinical outcomes. New stents which combine the anti-thrombotic coating with the drug delivery ability, such as radioactive stents, degradable stents and some new challenging trends which are mostly at research and development stage for stent surface coatings are also introduced.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Polymer Surface Interaction Studies · Electrospun Nanofibers in Biomedical Applications · Coronary Interventions and Diagnostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. 10.1161/01.CIR.0000019122.00032.DF10.1161/01.CIR.0000019122.00032.DF ↗
2. 10.1016/S0002-9149(00)00930-910.1016/S0002-9149(00)00930-9 ↗
3. Kutryk M. J. B., and Serruys P. W.: in ‘Textbook of interventional cardiology’, (ed.Topol E. J.), 4th edn, 591-630; 2003, Elsevier Science, London.
4. 10.1002/jbm.a.3002310.1002/jbm.a.30023 ↗
5. McNair A. M. · Med. Device Technol · 1996 · 7 · 16
6. 10.1615/JLongTermEffMedImplants.v12.i4.2010.1615/JLongTermEffMedImplants.v12.i4.20 ↗
7. 10.1016/0142-9612(84)90047-410.1016/0142-9612(84)90047-4 ↗
8. 10.22203/eCM.v005a0210.22203/eCM.v005a02 ↗
9. 10.1016/S0925-9635(03)00081-510.1016/S0925-9635(03)00081-5 ↗
10. Reifart N. · Cardiovas. Inter · 2004 · 18
11. 10.1161/01.CIR.103.3.42910.1161/01.CIR.103.3.429 ↗
12. Ohyama T. · Am. J. Neuroradia · 2004 · 25 · 53
13. 10.1016/S0002-9149(02)02206-310.1016/S0002-9149(02)02206-3 ↗
14. 10.1161/01.CIR.101.21.247810.1161/01.CIR.101.21.2478 ↗
15. Hehrlein C. · Coron. Artery Dis · 1995 · 6 · 581
16. 10.1177/09672109950030061810.1177/096721099500300618 ↗
17. 10.1016/0964-8305(92)90065-V10.1016/0964-8305(92)90065-V ↗
18. Ashby D. T. · Cardiovasc. Inter · 2002 · 83
19. 10.1016/j.amjcard.2004.09.01010.1016/j.amjcard.2004.09.010 ↗
20. Gercken U. · Cardiovasc. Inter · 2002 · 353
21. 10.1161/01.CIR.0000079106.71097.1C10.1161/01.CIR.0000079106.71097.1C ↗
22. Bhatt D. L., and Topol E. J.: in ‘Textbook of interventional cardiology’, (ed.Topol E. J.), 4th edn, 251-266; 2003, Philadelphia, PA, Elsevier Science.
23. Plum G. ‘Freisetzungsverhalten von unterschiedlich hydrophil/ hydrophoben Modellsubstanzen aus Poly-(D,L-lactid)- und Poly-(D,L-lactid)-co-PEO-co-poly-(D,L-lactid)-Mikrosphären und pharmazeutische Anwendungen’, PhD thesis, RWTH-Aachen, 2004.
24. Jung F. · Technik · 1998 · 43 · 47
25. Bolz A. · Tex. Heart Inst. J · 1996 · 23 · 162
26. 10.1034/j.1600-6143.2003.08058.x10.1034/j.1600-6143.2003.08058.x ↗
27. Rzany A. · Biomed. Technik · 1998 · 43 · 388
28. 10.1016/S0167-577X(03)00053-310.1016/S0167-577X(03)00053-3 ↗
29. 10.1016/S1389-0344(02)00042-410.1016/S1389-0344(02)00042-4 ↗
30. 10.1002/(SICI)1097-0304(199705)41:1<71::AID-CCD17>3.0.CO;2-T10.1002/(SICI)1097-0304(199705)41:1<71::AID-CCD17>3.0.CO;2-T ↗
31. Unverdorben M., Sippel B., Degenhardt R., Sattler K., Fries R., Abt B., Wagner E., Koehler H., Daemgen G., Scholz M., Ibrahim H., Tews K. H., Hennen B., Berthold H. K., and Vallbracht C.: Am. Heart 1, 2003,145, (4), e17.10.1067/mhj.2003.90 ↗
32. Hamm C. W., and Hugenholtz P. G.: Catheter. Cardiovasc. Interv.60, (2003), 375–381.10.1002/ccd.10656 ↗
33. Lau K. W., Johan A., Sigwart U., and Hung J. S.: Singapore Med J., 2004,45, (7), 305–312.
34. De Scheerder I. · J. Invasive Cardiol · 2000 · 12 · 389
35. 10.1016/S1389-0344(02)00029-110.1016/S1389-0344(02)00029-1 ↗
36. Gutensohn K., Beythien C., Bau J., Fenner T., Grewe P., Koester R., Padmanaban K., and Kuehnl P.: Thrombosis Res. 2000, 99, 577–585.10.1016/S0049-3848(00)00295-4 ↗
37. 10.1016/S0735-1097(98)00289-710.1016/S0735-1097(98)00289-7 ↗
38. Thierry B. · Proc. Eur. Symp. on ‘Vascular biomaterials (ESVB)’, European Society for Vascular Biomaterials, Mulhouse, France, 2001, · 101
39. 10.1016/S0002-9149(99)00874-710.1016/S0002-9149(99)00874-7 ↗
40. 10.1016/j.amjcard.2003.10.04810.1016/j.amjcard.2003.10.048 ↗
41. 10.1016/j.amjcard.2004.02.02910.1016/j.amjcard.2004.02.029 ↗
42. Haase J. · J. Invasive Cardiol · 2003 · 15 · 562
43. 10.1161/hc3401.09314610.1161/hc3401.093146 ↗
44. Windecker S. · Circulation · 2005 · 2
45. 10.1023/A:100893940081210.1023/A:1008939400812 ↗
46. Klee D., Weiss N., and Lahann J.: in ‘Modern cyclophane chemistry’, (ed.Hopf H., and Gleiter R.), 463-283; 2004, Weinheim, Wiley-VCH.10.1002/3527603964.ch18 ↗
47. Lahann J., Klee D., and Wicker H.: MacromoL Rapid Commun. 1998, 19, 441–444.10.1002/marc.1998.030190901 ↗
48. 10.1016/S0142-9612(00)00244-110.1016/S0142-9612(00)00244-1 ↗
49. 10.1148/radiol.230102107110.1148/radiol.2301021071 ↗
50. 10.1016/j.cardiores.2004.02.00110.1016/j.cardiores.2004.02.001 ↗
51. 10.1016/j.surfcoat.2004.08.11410.1016/j.surfcoat.2004.08.114 ↗
52. Amols H. I. · Radiat. Med · 1999 · 1 · 270
53. 10.1007/s15010-002-2338-010.1007/s15010-002-2338-0 ↗
54. Leitao E., Silva R. A., and Barbosa M. A.: J. Mater. Sci., Mater M, 1997, 8, 365–368.10.1023/A:1018532900458 ↗
55. 10.1016/S0969-8043(98)00180-810.1016/S0969-8043(98)00180-8 ↗
56. 10.1161/01.CIR.93.4.64110.1161/01.CIR.93.4.641 ↗
57. 10.1016/S0360-3016(98)00024-810.1016/S0360-3016(98)00024-8 ↗
58. 10.1161/01.CIR.101.1.1810.1161/01.CIR.101.1.18 ↗
59. 10.1161/01.CIR.100.16.168410.1161/01.CIR.100.16.1684 ↗
60. 10.1016/S0002-8703(03)00389-210.1016/S0002-8703(03)00389-2 ↗
61. 10.1161/hc4301.09787310.1161/hc4301.097873 ↗
62. 10.1007/s00392-002-0840-010.1007/s00392-002-0840-0 ↗
63. 10.2174/138161205338202510.2174/1381612053382025 ↗
64. Golombeck M. A. · Phys. Res. B · 2003 · 206 · 495
65. 10.1016/S1522-1865(99)00015-310.1016/S1522-1865(99)00015-3 ↗
66. 10.1016/S0360-3016(02)02960-710.1016/S0360-3016(02)02960-7 ↗
67. 10.1097/01.hco.0000142069.39957.0310.1097/01.hco.0000142069.39957.03 ↗
68. 10.2165/00129784-200404060-0000710.2165/00129784-200404060-00007 ↗
69. 10.1583/05-1525.110.1583/05-1525.1 ↗
70. 10.1161/01.CIR.0000163587.36485.A710.1161/01.CIR.0000163587.36485.A7 ↗
71. Merkli A. · Polym. Sc · 1998 · 563
72. 10.1016/S0735-1097(96)00584-010.1016/S0735-1097(96)00584-0 ↗
73. 10.1002/jbm.a.1015410.1002/jbm.a.10154 ↗
74. 10.1159/00005106710.1159/000051067 ↗
75. 10.1161/01.CIR.94.7.169010.1161/01.CIR.94.7.1690 ↗
76. 10.1016/j.ehj.2004.06.01010.1016/j.ehj.2004.06.010 ↗
77. 10.1007/s00104005073410.1007/s001040050734 ↗
78. 10.1161/01.CIR.102.4.39910.1161/01.CIR.102.4.399 ↗
79. 10.1007/s11886-001-0004-210.1007/s11886-001-0004-2 ↗
80. 10.1136/heart.89.6.65110.1136/heart.89.6.651 ↗
81. 10.1007/BF0283414010.1007/BF02834140 ↗
82. 10.1111/j.1540-8183.2004.04081.x10.1111/j.1540-8183.2004.04081.x ↗
83. 10.1161/01.CIR.0000014612.88433.6210.1161/01.CIR.0000014612.88433.62 ↗
84. 10.1161/hq0901.09449310.1161/hq0901.094493 ↗
85. 10.1583/04-1349R.110.1583/04-1349R.1 ↗
86. 10.1016/0142-9612(86)90068-210.1016/0142-9612(86)90068-2 ↗
87. 10.1016/S0142-9612(00)00083-110.1016/S0142-9612(00)00083-1 ↗
88. 10.3109/1073119830911880410.3109/10731198309118804 ↗
89. Fischell T. A., Carter A. J., and Laird J. R.: Am. J. Cardiol., 1996, 78 (Suppl 3A),45–50.10.1016/S0002-9149(96)00489-4 ↗
90. 10.1146/annurev.physiol.66.032902.13183510.1146/annurev.physiol.66.032902.131835 ↗
91. 10.1016/0142-9612(86)90045-110.1016/0142-9612(86)90045-1 ↗
92. 10.1136/heart.83.3.33810.1136/heart.83.3.338 ↗
93. Nakaya T. · Polym. Sc · 1999 · 143
94. 10.1016/S0142-9612(01)00297-610.1016/S0142-9612(01)00297-6 ↗
95. 10.1016/S0927-7765(99)00152-610.1016/S0927-7765(99)00152-6 ↗
96. 10.1016/0142-9612(94)90025-610.1016/0142-9612(94)90025-6 ↗
97. 10.1053/euhj.1999.154910.1053/euhj.1999.1549 ↗
98. 10.1080/1462884005051596610.1080/14628840050515966 ↗
99. 10.1016/S0002-9149(00)00951-610.1016/S0002-9149(00)00951-6 ↗
100. Ratner B. D., Hoffman A. S., Schoen F. L., and Lemons J. E. (ed. by Ratner B. D., and Hoffman A. S.): ‘Biomaterials science: an introduction to materials in medicine’; 1996, Acadmic Press Inc.10.1016/B978-012582460-6/50002-5 ↗